The results generated by TIP reproduced the results from the xCELL-based approach, increasing our confidence that stroma-corrected ZEB1 expression is indeed associated with decreased immune cell abundance and antitumor immune activity in breast cancer. The gene discussed is ZEB1; the disease is breast carcinoma.